Enavogliflozin/Metformin Hydrochloride
- Generic Name
- Enavogliflozin/Metformin Hydrochloride
A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 37
- Registration Number
- NCT05192395
- Locations
- 🇰🇷
CHA unuversity bundang medical center, Seongnam, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath